Defects in Notch1 upregulation upon activation of T cells from patients with systemic lupus erythematosus are related to lupus disease activity

Lupus

Volumn 17, Issue 7, 2008, Pages 645-653

  Sodsai, P ^a   Hirankarn, N ^a   Avihingsanon, Y ^a   Palaga, T ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Activation; Disease activity; Notch receptor; SLE; T cells

Indexed keywords

MESSENGER RNA; NOTCH1 RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME DEFECT; FEMALE; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 48249131270     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308089406     Document Type: Article

References (41)

1. Mills, JA. Systemic lupus erythematosus. N Engl J Med 1994; 26: 1871-1879.
2. Lipsky, PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2001; 9: 764-766.
3. Hoffman, RW. T cells in the pathogenesis of systemic lupus erythematosus. Clin Immunol 2004; 1: 4-13.
4. Maddison, PJ, Reichlin, M. Quantitation of precipitating antibodies to certain soluble nuclear antigens in SLE. Arthritis Rheum 1977; 3: 819-824.
5. Takeuchi, T, Tsuzaka, K, Abe, T, et al. T cell abnormalities in systemic lupus erythematosus. Autoimmunity 2005; 5: 339-346.
6. Crispin, JC, Martinez, A. Alcocer-Varela, J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003; 3: 273-276.
7. Liu, MF, Wang, CR, Fung, LL, Wu, CR. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004; 2: 198-202.
8. Alvarado-Sanchez, B, Hernandez-Castro, B, Portales-Perez, D, et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2006; 2: 110-118.
9. Takeuchi, T, Tsuzaka, K, Kameda, H, Amano, K. Therapeutic targets of misguided T cells in systemic lupus erythematosus. Curr Drug Targets Inflamm Allergy 2005; 3: 295-298.
10. Artavanis-Tsakonas, S, Rand, MD, Lake, RJ. Notch signaling: cell fate control and signal integration in development. Science 1999; 5415: 770-776.
11. Radtke, F, Wilson, A, Mancini, S, MacDonald, H. Notch regulation of lymphocyte development and function. Nat Immunol 2004; 247-253.
12. Osborne, BA, Minter, LM. Notch signalling during peripheral T-cell activation and differentiation. Nat Rev Immunol 2007; 1: 64-75.
13. Anastasi, E, Campese, AF, Bella via, D, et al. Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes. J Immunol 2003;9:4504-4511.
14. Hoyne, GF, Le Roux, I, Corsin-Jimenez, M, et al. Serrate 1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells. Int Immunol 2000; 2: 177-185.
15. Ostroukhova, M, Qi, Z, Oriss, TB, Dixon-McCarthy, B, Ray, P, Ray, A. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J Clin Invest 2006; 4: 996-1004.
16. Minter, LM, Turley, DM, Das, P, et al. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat Immunol 2005; 7: 680-688.
17. Tournoy, J, Bossuyt, X, Snellinx, A, et al. Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice. Hum Mol Genet 2004; 13: 1321-1331.
18. Xu, L, Zhang, L, Yi, Y, Kang, HK, Datta, SK. Human lupus T cells resist inactivation and escape death by upregulating COX-2. Nat Med 2004; 4: 411-415.
19. Khanna, S, Pal, H, Pandey, RM, Handa, R. The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology (Oxford) 2004; 12: 1536-1540.
20. Arce-Salinas, A, Cardiel, MH, Guzman, J, Alcocer-Varela, J. Validity of retrospective disease activity assessment in systemic lupus erythematosus. J Rheumatol 1996; 5: 846-849.
21. Palaga, T, Miele, L, Golde, TE, Osborne, BA. TCR-mediated Notch signaling regulates proliferation and IFN-gamma production in peripheral T cells. J Immunol 2003; 6: 3019-3024.
22. Adler, SH, Chiffoleau, E, Xu, L, et al. Notch signaling augments T cell responsiveness by enhancing CD25 expression. J Immunol 2003; 6: 2896-2903.
23. Garcia-Cozar, FJ, Molina, IJ, Cuadrado, MJ, Marubayashi, M, Pena, J, Santamaria, M. Defective B7 expression on antigenpresenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients. Clin Exp Immunol 1996; 1: 72-79.
24. Wouters, CH, Diegenant, C, Ceuppens, JL, Degreef, H, Stevens, EA. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Br J Dermatol 2004; 4: 693-700.
25. Ansel, KM, Djuretic, I, Tanasa, B, Rao, A. Regulation of Th2 differentiation and 114 locus accessibility. Annu Rev Immunol 2006; 607-656.
26. McKenzie, G, Ward, G, Stallwood, Y, et al. Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals. BMC Cell Biol 2006; 10.
27. Maekawa, Y, Tsukumo, S, Chiba, S, et al. Deltal-Notch3 interactions bias the functional differentiation of activated CD4+ T cells. Immunity 2003; 4: 549-559.
28. Lit, LC, Wong, CK, Li, EK, Tam, LS, Lam, CW, Lo, YM. Elevated Gene Expression of ThTh2 Associated Transcription Factors Is Correlated with Disease Activity in Patients with Systemic Lupus Erythematosus. J Rheumatol 2007; 1: 89-96.
29. Mok, CC, Lau, CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003; 7: 481-490.
30. Kared, H, Adle-Biassette, H, Fois, E, et al. Jagged2-expressing hematopoietic progenitors promote regulatory T cell expansion in the periphery through notch signaling. Immunity 2006; 5: 823-834.
31. Qi, R, An, H, Yu, Y, et al. Notchl signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res 2003; 23: 8323-8329.
32. Eagar, TN, Tang, Q, Wolfe, M, He, Y, Pear, WS, Bluestone, JA. Notch 1 signaling regulates peripheral T cell activation. Immunity 2004; 4: 407-415.
33. Gottlieb, AB, Lahita, RG, Chiorazzi, N, Kunkel, HG. Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen. J Clin Invest 1979; 5: 885-892.
34. Stohl, W. Impaired generation of polyclonal T cell-mediated cytolytic activity despite normal polyclonal T cell proliferation in systemic lupus erythematosus. Clin Immunol Immunopathol 1992; 2: 163-172.
35. Tada, Y, Nagasawa, K, Yamauchi, Y, Tsukamoto, H, Niho, Y. A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1991; 2:220-231.
36. Stahl, M, Ge, C, Shi, S, Pestell, RG, Stanley, P. Notch1-induced transformation of RKE-1 cells requires up-regulation of cyclin D1. Cancer Res 2006; 15: 7562-7570.
37. Sarmento, LM, Huang, H, Limon, A, et al. Notchl modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation. J Exp Med 2005; 1: 157-168.
38. Weng, AP, Millholland, JM, Yashiro-Ohtani, Y, et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 2006; 15: 2096-2109.
39. Curry, CL, Reed, LL, Nickoloff, BJ, Miele, L, Foreman, KE. Notch-independent regulation of Hes-1 expression by c-Jun N-terminal kinase signaling in human endothelial cells. Lab Invest 2006; 8: 842-852.
40. Shin, HM, Minter, LM, Cho, OH, et al. Notchl augments NF-kappaB activity by facilitating its nuclear retention. Embo J 2006; 1: 129-138.
41. Wong, HK, Kammer, GM, Dennis, G, Tsokos, GC. Abnormal NF-kappaB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. J Immunol 1999; 3: 1682-1689.